Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 1,076 | 1,026 | 329 | 0 | 0 |
| Gross Profit | 1,076 | 1,026 | 329 | N/A | N/A |
| Operating Expenses | 7,988 | 7,354 | 7,547 | 7,324 | 5,943 |
| Operating Income | -6,912 | -6,328 | -7,218 | -7,324 | -5,943 |
| Interest Expense | 537 | 562 | 563 | 558 | 291 |
| Other Income | 3 | 4 | 2 | 1 | 1 |
| Pre-tax Income | -7,446 | -6,886 | -7,779 | -7,881 | -6,233 |
| Net Income Continuous | -7,446 | -6,886 | -7,779 | -7,881 | -6,233 |
| Net Income | $-7,446 | $-6,886 | $-7,779 | $-7,881 | $-6,233 |
| EPS Basic Total Ops | -0.23 | -0.24 | -0.33 | -0.38 | -0.31 |
| EPS Basic Continuous Ops | -0.23 | -0.24 | -0.33 | -0.38 | -0.30 |
| EPS Diluted Total Ops | -0.23 | -0.24 | -0.33 | -0.38 | -0.31 |
| EPS Diluted Continuous Ops | -0.23 | -0.24 | -0.33 | -0.38 | -0.30 |
| EBITDA(a) | $-6,658 | $-6,096 | $-7,013 | $-7,152 | $-5,811 |